Lung transplantation for chemotherapy-induced pulmonary fibrosis.
A 26-year-old man cured of childhood acute lymphoblastic leukemia underwent a single lung transplant for drug-induced pulmonary toxicity 9 years after the completion of chemotherapy. It is not known whether patients cured of a malignancy who undergo organ transplantation are at increased risk of malignancy as compared to other organ transplant recipients. There was no evidence of recurrent or secondary malignancy in this case. Since single lung transplantation has been effective for idiopathic pulmonary fibrosis, it should be considered for patients cured of a malignancy who develop chemotherapy-induced pulmonary fibrosis.
Santamauro
J T
JT
Pulmonary Service, Memorial Sloan Kettering Cancer Center, New York 10021.
Stover
D E
DE
Jules-Elysee
K
K
Maurer
J R
JR
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D004417:Dyspnea / Q000209:etiology; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D016040:Lung Transplantation; D008297:Male; D011014:Pneumonia / Q000209:etiology; D011658:Pulmonary Fibrosis / Q000139:chemically induced* / Q000601:surgery*